Announcements Trials

Browse Landscape

Phase

Phase 3 1 Phase 2/3 1 Phase 2 1 Phase 1 1

Status

Terminated 2 Unknown 1 Completed 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Triple Negative Breast Neoplasms 1

Interventions

Cisplatin 267 Oxaliplatin 194 Carboplatin 189 Capecitabine 183 Docetaxel 176 apatinib 164 Paclitaxel 158 Bevacizumab 155 Gemcitabine 154 Radiotherapy 146 camrelizumab 145 Fluorouracil 144 Cyclophosphamide 123 Irinotecan 119 Drug Therapy 118 sintilimab 107 Etoposide 99 anlotinib 90 S 1 (combination) 88 Leucovorin 85 pembrolizumab 82 Pemetrexed 78 Doxorubicin 77 toripalimab 76 tislelizumab 75 Dexamethasone 70 Trastuzumab 65 Neoadjuvant Therapy 64 Rituximab 62 Cetuximab 61

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Unknown × AC protocol × Clear all

NCT04248998 2023-01-18

BREAKFAST

Fondazione IRCCS Istituto Nazionale dei Tumori, Milano

Phase 2 Unknown

Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡